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The whole world is facing a big challenge to fight against COVID-19 as it is a novel disease, highly infectious and 
having no treatment yet. Traditional Unani medicine is reviewed with an aim to find some solution for this disease 
prevention, control and management. Unani medical literature is extensively reviewed and it is found that there are some 
presentations similar to this disease and management of those clinical syndromes could be applied in present scenario. Major 
symptoms like fever, cough, fatigue, shortness of breath and rhinorrhoea are reviewed from Unani medical text having 
similar aetiology and interlinked pathology. It is demonstrated that in cold & humid atmospheric conditions in persons 
having Fuzlat (waste) in their body, Nazla (fall) of Balghami Rutubaat (phlegmatic fluids) from head comes towards lungs, 
infected there resulting in Zatur Riya (pneumonia/pneumonitis) and Humma Mawazba (fever caused by abnormal humour 
Balgham) and /or Humma Mutbiqa (fever caused by abnormal humour Dam). The bad atmospheric condition favours spread 
of this infection to other people who come in contact with such patient. The detailed description of these Unani concepts & 
interpretation is given below. 
Keywords: COVID-19, Humma Balghami, Nazla, Unani pathology, Waba 
IPC Code: Int. Cl.20: A61K 36/00, A61K 47/00 
Till date no treatment or vaccine is available for 
COVID-19 caused by SARS-CoV-2(ref.1). The priority 
of medical fraternity in this situation is to control the 
outbreak using all available safe and effective modes 
of treatment and prevention. Instead of declaring 
unscientific and ineffective, it is wise to assess the 
efficacy of traditional medicines which are safe to 
humans and has been in practice since long time for 
diseases having similar clinical presentation2. Due to 
the holistic approach of Unani Medical system, one 
drug may be used in several kind of illnesses. Unani 
medicine has previously found effective in certain 
difficult to treat diseases of inflammatory, 
autoimmune and idiopathic nature2. Various Unani 
drugs have been found to have immunomodulator and 
antiviral properties. Many upper and lower respiratory 
symptoms could be managed with Unani medicines 
including dry cough, dyspnoea, flu etc.3 Each 
symptom is treated only after establishing its holistic 
pathology & diagnosis. In comparison to the 
development of new drug, it is easier to repurpose 
existing drugs on scientific grounds. Hence, it is 
inevitable to review and anatomise the Unani medical 
pathology of symptoms found in COVID-19 so that 
traditional medicines already in practice may be 
utilised and assessed for this new indication. 
Causes and risk factors 
Coronavirus disease 2019 (COVID-19) caused by a 
new virus, SARS-CoV-2 (severe acute respiratory 
syndrome coronavirus 2) of family Coronaviridae, is a 
highly infectious disease1. Age is a strong risk factor 
for severity of disease, development of complications, 
and chances of mortality. The case fatality rate among 
more than 40,000 cases of COVID-19 in China, was 
highest in elderly persons viz., 14.8% in ≥80 years, 
8.0% in 70–79 years, 3.6% in 60–69 years,1.3% in 
50–59 years, 0.4% in 40–49 years, 0.2% in <40 years. 
Early epidemiologic data of U.S. suggest that the case 
fatality was highest (10%–27%) in patients aged ≥85 
years, followed by 3%–11% in ages 65–84 years, 
1%–3% in ages 55–64 years, and <1% in ages <54 
years. Patients without comorbidity had an overall 
case fatality of 0.9%, but it was higher for patients 
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with underlying medical conditions e.g. 10.5% for 
those with cardiovascular disease, 7.3% for diabetes, 
and nearly 6% each for hypertension, chronic 
respiratory disease, and cancer. Prior stroke and 
chronic kidney disease also have been associated with 
increased severity of illness and adverse fate. In terms 
of age differences and prevalence of comorbidity, 
COVID-19 associated mortality in the United States 
was similar to China4. 
 
Clinical features of COVID-19 
The incubation period for COVID-19 is considered 
up to 14 days, with a median time of 4-5 days. One 
study reported that 97.5% of persons develop 
symptoms within 11.5 days of SARS-CoV-2 infection. 
The signs and symptoms of COVID-19 vary at illness 
onset, but over the course of the disease, patients with 
COVID-19 experience the following features: Fever 
(83–99%), Cough (59–82%), Fatigue (44–70%), 
Anorexia (40–84%), Shortness of breath (31–40%), 
Sputum production (28–33%), Myalgias (11–35%)4. 
Headache, confusion, rhinorrhoea, sore throat, 
haemoptysis, vomiting, and diarrhoea have been less 
commonly observed (<10%). Some persons with 
COVID-19 have experienced gastrointestinal 
symptoms such as diarrhoea and nausea before 
developing fever and lower respiratory tract 
symptoms. Anosmia or ageusia prior to onset of 
respiratory symptoms has been reported, but more 
information is required to understand its part in 
diagnosing COVID-19. Several studies have reported 
similar signs and symptoms of COVID-19 in children 
than adults but usually milder. SARS-CoV-2 infection 
is documented in asymptomatic patients (who never 
develop symptoms) and in pre-symptomatic patients 
(not yet symptomatic). Abnormalities on chest 
imaging are reported in patients before the onset of 
symptoms. Some data suggest that in younger 
individuals, mostly pre-symptomatic infection is 
detected and viral pneumonia is less likely associated. 
Although transmission of SARS-CoV-2 from 
asymptomatic or pre-symptomatic patients has been 
documented, risk of transmission may be greatest 
when patients are symptomatic. Viral RNA shedding 
is greatest at the onset of symptom and declines over 
the course of several days to weeks, as measured 
indirectly by RT-PCR cycle threshold values. The 
exact degree of SARS-CoV-2 viral RNA shedding 
that may provoke risk of transmission is not yet clear4. 
The largest cohort of >40,000 persons with confirmed 
COVID-19 from China indicated that disease severity 
can range from mild to critical4: 
 Mild to moderate (mild symptoms up to mild 
pneumonia): 81% 
 Severe (dyspnoea, hypoxia, or >50% lung 
involvement on imaging): 14% 
 Critical (respiratory failure, shock, or multiorgan 
system dysfunction): 5% 
In this study, all deaths observed among patients 
with critical condition and the overall case fatality rate 
was 2.3%. The case fatality rate in patients with critical 
disease was 49%. Among children in China, disease 
severity was lower with 94% having asymptomatic, 
mild or moderate disease, 5% having severe illness and 
<1% having critical disease. Only one (<0.1%) death 
was noted in a person <18 years old4. 
 
Unani perspective of COVID-19 
For interpreting any new disease, not existing in 
past era or in current medical literature, we need to 
assess their clinical features and possible aetiology. 
Correlation of symptoms and causes of new disease 
with those previously described, facilitates 
comprehensive guidance to define the pathology and 
management. In Unani medical literature we did not 
find any disease having exactly similar clinical 
condition to that of COVID-19, but with the help of 
holistic description of these symptoms and their 
relations with probable causes it is attempted to 
explain the Unani medical perspective of this disease. 
Major symptoms like fever, cough, fatigue, shortness 
of breath and rhinorrhoea are reviewed from Unani 
medical text having similar aetiology and interlinked 
pathology. It is demonstrated that in cold and humid 
atmospheric conditions in persons having Fuzlat 
(waste) in their body Nazla (fall) of  Balghami 
Rutubaat (phlegmatic fluids) from head comes 
towards lungs, infected there and result in Zatur Riya 
(pneumonia/pneumonitis) and Humma Mawazba 
(fever caused by abnormal humour Balgham) and /or 
Humma Mutbiqa (fever caused by abnormal humour 
Dam). The bad atmospheric condition favours spread 
of this infection to other people who come in contact 
with such patient. The detailed description of this 
Unani concepts and interpretation is given below. 
 
Unani medical concepts related to COVID-19 
 
Waba and Humma Wabai 
Waba is defined as an abnormal health condition 
where a large number of population is involved in  




one particular disease. Its modern synonym may be 
epidemic or pandemic5. According to Avicenna, 
Waba is caused by severe perverted conditions of air 
and earth. Change of weather (climate) is of primary 
importance in Waba and is related to change in sky 
conditions which we do not know specifically. Often 
causes of infection are earth related, the details of 
which are not known to us. Often Ajsame Khabeesa 
(infectious agents) play a role in spread of infection. 
Waba may be cold or hot depending on its time & 
condition of origin. Waba which is originated in dry 
atmosphere ends early but that started in humid 
atmosphere last longer6. 
Here, Avicenna clearly stated that some things in 
origin of infection and its spread is not known 
specifically. Unani physicians have even pointed 
towards some invisible bodies and Ajsame Khabeesa 
(infectious agents) involved in the process of infection 
but not about the viruses and their characteristics7. 
It is quite obvious that this disease COVID-19 
outbreak occurred in winter season and in humid 
atmosphere. Wuhan is divided by the rivers Yangtze 
and Han. This city comprises several lakes and parks 
including expansive picturesque East Lake8. The 
humidity of city is relatively high and the temperature 
of city during the outbreak was low. The disease was 
first noticed in seafood workers. So, the nature of 
Waba is most likely to be considered as cold and wet. 
Humma Wabai (Humma means Fever in Arabic) is 
among several diseases which are classified in Waba. 
According to Avicenna, Humma Wabai starts from 
humid air. In humid air fevers last longer though are 
less severe in intensity. Humma Wabai is noticed mild 
externally (low grade fever) but internally it is worse 
and even fatal. It is characterised by difficulty in 
breathing, bad odour from mouth, restlessness, dry 
cough, unconsciousness, lethargy, diarrhoea6. 
 
Humma Balghami, Humma Mawazba and Humma Mutbiqa 
The etiologic type of Humma which is likely to be 
considered for this disease is Humma Balghami. 
Humma Balghami is caused by infection of abnormal 
Balgham (one of the four basic humours of the body 
having cold and wet nature). Majoosi has stated that 
winter season, humid and cold climate, and flowing 
winds are predisposing factors for Humma Balghami. 
Humma Balghami occurs in adolescents or elderly. 
They have propensity to develop it because they have 
excess Balgham in their body9. We are observing 
somewhat similar pattern of this disease in the 
community. 
Among few types of Humma Balghami, 
characteristics of Humma Mawazba are similar to the 
disease under discussion. The diagnosis of Humma 
Mawazba may be confirmed if illness occurred in one 
particular season globally9. In Humma Mawazba, 
Balgham is infected outside the blood vessels in 
organs like stomach or lung. Fever remains for 18 h 
daily but does not go off completely. Chills may be 
present or absent. Chills found more in Balgham 
Zujaji and least or absent in Balgham Haad (Zujaji 
and Haad are types of abnormal Balgham). 
Unconsciousness may develop because of loss of 
appetite. Balghami vomiting and diarrhoea may 
occur. Colour of body may be bluish white10. 
Sometimes lips become bluish like those who eat 
toot6. 
Unani physicians have described different aetiology 
of different fevers based on their pattern and course. In 
Hummiyate Murakkaba (fever which is supposed to be 
caused by more than one abnormal humour) symptoms 
overlap, course of fever depends on the causative 
matter. If hot humour is mixed with cold one, the 
duration and severity of fever caused by cold humour 
decreases based on quantity of hot humour10. It is 
mentioned that Balgham is a humour which may be 
converted in Dam in need under influence of Hararate 
Ghareezi (Normal body temperature). Similarly, due to 
action of Hararate Ghareebi (abnormal body 
temperature), the nature of abnormal Balgham may be 
changed to abnormal hot humour. According to 
Majoosi, Humma Mawazba may be mixed with 
Humma Mutbiqa. Mutbiqa is caused by abnormal 
conditions in humour Dam (hot and wet in nature). The 
patient of Mutbiqa feels lethargy, fatigue, weakness, 
thirst and difficulty in breathing9. 
 
Cough, Nazla and Dyspnoea 
Nazla is a concept in Unani medicine which means 
fall of waste fluid from head to downwards usually in 
respiratory passages. Unani physician Ahmad bin 
Muhammad Tabri (10th Century AD) explained an 
interesting pathogenesis of a diseases he named it 
‘Waram (inflammation) of Nazla in Chest’ which is 
very much similar to our interpretation for COVID-
19. According to him, ‘Ghaleez (thick) or Raqeeq 
(thin) Rutubaat (fluids) falling from head causes this 
disease. Usually this Rutubaat are Raqeeq, Haad 
(acute) and Akkal (corrosive or erosive) but 
sometimes may be Ghaleez and Haad. The 
pathogenesis is explained as follows: Ghaleez Damwi 
(related to humour Dam) or Safrawi (related to 




humour Safra) Bukharat (vapours) ascends from 
whole body and get accumulated in head due to 
closure of Masamat of head in cold. After significant 
amount collected in head these are expelled towards 
chest and sometimes other adjacent structures11. 
According to Majoosi, cough due to lung diseases 
may be caused by Nazla. Nazla containing Fuzla 
(waste matter) of head when descends to lungs and 
chest may induce severe cough especially when it is 
acute, thin and corrosive in nature. Such material 
when attempted to expectorate causes severe 
coughing because it does not come out easily (dry 
cough) and more force is induced to expectorate it. 
Due to forcible act of coughing there are chances of 
haemorrhage in vessels of lung manifesting clinically 
as haemoptysis.  Ultimately severe coughing and this 
noxious morbid matter in the lungs lead to ulceration 
and wound there. In this condition, occasionally 
Raqeeq Balgham (thin sputum) is expectorated and 
sometimes Ghaleez Sabz Balgham (greenish viscous 
sputum). Few patients develop fever (Hummiyate 
Mukhtaleta/Murakkaba)9. The autopsy of COVID 19 
patients’ lungs show that the consistency of tissue 
changed from normal soft spongy to gelatinous hard12. 
The nature of morbid matter Balgham lazij described 
in Unani text corresponds with this morphology13. 
 
Unani concept of pneumonitis 
Zatur Riya (pneumonia/pneumonitis) caused by 
Barid Nazlat descended to lungs from head cause 
difficulty in breathing and heaviness in chest, eyes and 
tongue11. Dyspnoea and many respiratory diseases are 
named as Sil because the respiratory organs weaken 
and their functions decrease. (Sil in Arabic means 
weak). Sil may spread to others who come in contact 
with such patient9. Majoosi has documented that such 
respiratory diseases are communicable but he could not 
establish the factors of disease transmission here. 
According to Tabri, a type of Sil called as Silul Minfar 
produced by wound in lungs caused by Haad Akkal 
humour. It leads to continuous fever and deterioration 
of Quwwat of body (Immunity). Due to Waram 
(inflammation) in lungs exchange of gases becomes 
difficult. Inability of getting fresh air leads to difficulty 
in neutralising warm air in heart which becomes unable 
to work properly. Excess of heat in heart is the cause of 
fever. Severe cough along with haemoptysis and 
continuous fever leads to fatality11. With description of 
Sil by Tabri we may suggest that Sil should not be 
termed for tuberculosis exclusively but is a wider 
concept. Sil may be called for conditions like 
respiratory failure and multiorgan failure. The 
description of Sil may include the respiratory distress 
associated with critical illness of COVID-19. 
 
Unani medical view of Cytokine storm syndrome  
Possible causes of death in COVID-19 are 
respiratory failure, or cytokine storm syndrome. The 
term “Cytokine Storm Syndrome” (CSS) was coined to 
explain the observation that multiple inflammatory 
causes can result in a disease that looks very similar to 
sepsis. The unifying characteristic of CSS is a clinical 
and laboratory phenotype suggestive of massive 
inflammation progressing to multiple organ 
dysfunction syndrome (MODS) and eventually death14. 
Avicenna has ascertained that if dyspnoea occurs 
suddenly the cause will be Nazla. Sometimes these 
morbid matters accumulate in Urooqe Khashina 
(bronchioles) that may cause Khafqan and may be 
fatal. If Hejan (storm of humours) or Imtila 
(congestion) appear in the morbid matter and in nearby 
structures of lung it may worsen the breathless 
condition6. The description of CSS may correspond to 
Hejan or Imtila mentioned by Avicenna. 
 
Coagulopathy and Unani Medicine 
Recent studies show that coagulopathy occurs in 
many patients with COVID-19 and it is associated with 
an increased death risk. The most typical findings in 
this pathological scenario are raised D-dimer 
concentration, relative low platelet count, and increased 
prothrombin time. It was reported that the 
coagulopathy related with COVID-19 is a combination 
of mild Disseminated Intravascular Coagulopathy and 
localised pulmonary thrombotic microangiopathy. 
These pathological conditions could be having a 
substantial impact on organ dysfunction in patients 
who are most severely affected. According to Unani 
literature, the causes of obstruction (sudda) due to 
abnormalities in quality are Ghilzat (increased 
viscosity), Lazoojat, Khoone Munjamid (clotted blood) 
or severe Buroodat, most of these could be associated 
with abnormal Balgham6. It hints towards association 
of thrombosis with abnormal Balgham. Obstruction in 
the vessels especially arteries is considered difficult to 
treat. Unani etiopathology for most of thromboembolic 
phenomenon are attributed to abnormal Balgham like 
in cases of paralysis6. Although Unani medical 
description presented here may be similar to COVID-
19, it is not contended specific to this disease. These 
points are based on qayas (Hypothesis) on literature of 
COVID-19, and interviews of recovered patients 




available online as direct observation of such cases 
(which is best way of Unani diagnosis) is difficult due 
to certain reasons. A brief view of Unani pathology is 
summarized in Fig. 1. 
 
Unani preventive measures 
Based on the amount of Fuzlat (wastes) in body, 
preventive measures taken, Mizaj and Quwwat in the 
body disease severity may be explained in Unani 
context. Those do not have Fuzlat in their body, 
detoxifying regularly, having Mizaj opposite to 
disease remain away from disease6,9. So holistically 
one should use preventive measures of opposite 
nature to disease13. Generally hot and dry climate, 
separation from diseased person, moderate diet, 
removal of wastes and excess Balghami Rutubaat, 
empowering body immunity, avoiding excess 
physical activities and optimum sleep helps to prevent 
from such diseases. Loban and camphor have 
disinfectant properties, hence fumigations of loban 
and use of camphormay purify ambient air16. It is 
evident that favourable environment for virus 
propagation and transmission is cold and moist so our 
surroundings should be hot and dry for this we should 
avoid use of ACs and air coolers as much as possible. 
Smelling spices like clove, cardamom is advisable. 
Use of Vinegar and other sour food is advisable like 
lemon, Achar etc. Cow Ghee is very effective to 
prevent from infection to be used orally and applied 
on the body. Barley and its water are good diet in 
days of Waba. Diet should be minimized to slightly 
lesser than usual habit. Milk, fruits and its juices 
(except citrus), alcohol should largely be avoided. Use 
of certain Unani medicines can help in protection 
from disease if taken before infection e.g. Tiryaqe 
Arba’a, Saffron, Arqe Ajeeb and Khameera 
Marwareed. Mild to moderate exercise especially 
walking is beneficial. According to Hippocrates, 
walking is man’s best medicine. According to 
Avicenna, exercise is the key of good health if it is 
done at correct time and in moderate quantity. 
According to Averroes, exercise generates some sort 
of heat that resembles to Hararate Ghareezi (essential 
quality of living body for normal physiology). Heavy 
physical activities must be avoided. One should 
remain calm and hopeful, keeping depression and fear 
away from him. Excess of anxiety, fear and 
hopelessness weakens the Hararate Ghareezi and 
makes body prone to diseases and infections. Rest is 
better with optimum sleep. Majoosi stated that Tabi’at 
(Immunity) is improved in two ways by sleep. One is 
mental and physical rest. Second is the digestion and 
yield of energy. Lack of sleep causes dissolution of 
energies, mental weakness and digestive upsets. It is 
necessary not to let bowel constipated as abnormal 
retention of faecal matter predisposes to infection6,17-20. 
 
Management approaches 
The Unani medical management of infectious 
respiratory diseases has been in practice. Apart from 
respiratory health benefits, Unani drugs are having 
other beneficial systemic effects like cardioprotective, 
hepatoprotective and nephroprotective, 
immunomodulatory, antiviral and antibacterial 
effects. The above description of clinical presentation 
from Unani medical literature has its treatment 
according to the etiopathology as follows: 
In treatment Fasd, prevention of fall of nazla, 
istefragh of morbid humours are useful6. After Fasd, 
Barley water, Unnab, Sapistan, Parsiyaoshan, 
Khashkhash safed, Badam Shirin, Aslussus, Maweez 
(Munaqqa), Zoofa are advisable. Zoofa, Aslussoos, 
Banafsha, Honey and Barley water are effective 
medicines for this type of Zatur Riya11. Maul Asal, 
Sikanjabeen Asali, Zoofa, Maul Usool (Bekhe Karafs, 
Bekhe Badyan, Bekhe Izkhir, Parsiyaoshan, Anisoon), 
Tiryaqe Arba’a are effective for Humma Mawazba10. 
Avicenna has mentioned drugs like abhal, suad kofi, 
izkhir, waj turki, kundur, hilteet, qaranfal, honey, 
zafran, sibr, mur makki, sirka, sandal, kafoor for 
prevention and treatment6. Pharmacological effects of 
Unani drugs mentioned here are shown in Table 1 
respectively3,21. Use of traditional Chinese medicine 
in recent COVID-19 outbreak of China resulted in 




Fig. 1 — Unani pathological overview of COVID-19 




Kalonji (Nigella sativa) has been traditionally used 
for the management of several symptoms and 
ailments including asthma, bronchitis, loss of appetite, 
diarrhoea, vomiting and it is also recommended for 
Humma Balghami6. It was reported that Nigella sativa 
has inhibitory actions against inflammatory cytokines 
such as interleukin-1 and 6 and the transcription 
factor, nuclear factor κB. Nigella sativa is having a 
 
Table 1 — Pharmacological effects of Unani drugs that may be used for COVID-19 
Unani Medicine Botanical name Traditional & Scientific Pharmacological effects 
Unnab Ziziphus jujube Mill. Antitussive, antiallergic; hepatoprotective, prevents stress induced ulcer formation, used
for dry cough 
Barley Hordeum vulgare Linn. Protects immune system, nutritive and demulcent in cases of bowel inflammation and 
diarrhoea. 
Sapistan Cordia dichotoma Expectorant, diuretic, mucilaginous, anthelmintic. It is used in the diseases of the chest
and urinary passage 
Parsiyaoshan Adiantum capillus- 
veneris Linn. 






used in catarrh, spasmolytic, devoid of narcotic properties 
Badam Shirin Prunus amygdalus  
Batsch var. 
Nutritious, demulcent and stimulant nervine tonic; valuable dry fruit in diets 
Maweez  
(Munaqqa) 
Vitis vinifera Linn. It is used in prescriptions for cough, respiratory tract catarrh, subacute cases of enlarged
liver and spleen 
Zoofa Hyssopus officinalis  
Linn. 
Stimulant, anti-inflammatory, diuretic, antispasmodic, used for bronchitis, coughs and
colds. It induces heavy sweating in fevers 
Aslussoos Glycyrrhiza glabra  
Linn. 
Expectorant, antiallergic, anti-inflammatory, mild laxative, spasmolytic, anti-stress, anti-
depressive, antiulcer, hepatoprotective, used in bronchitis, dry cough, respiratory
infections, catarrh, tuberculosis; Also used for adrenocorticoid insufficiency 
Banafsha Viola odorata Linn. Expectorant, anti-inflammatory, antipyretic, diaphoretic, diuretic. Used for catarrhal and
pulmonary affections, also for diseases of liver and intestines. 
Karafs Apium graveolens  
Linn. 
Anti-inflammatory (used in rheumatic disorders, inflammation of the urinary tract),
diuretic, carminative, nervine, sedative, antiemetic, antispasmodic, antiseptic (used in
bronchitis, asthma, as well as diseases of liver and spleen) 
Badyan Foeniculum vulgare  
Mill. 
Carminative, antispasmodic, anti-inflammatory, diuretic. Relieves bloating, nausea, used 
for the catarrh  
Izkhir Cymbopogon jwarancusa 
Schult. 
Blood purifier, febrifuge, antimicrobial, styptic 
Anisoon Pimpinella anisum Linn. Diuretic, antispasmodic, expectorant. It is used for flatulence, dry coughs, whooping
cough, bronchitis, catarrhs 
Abhal  Juniperus communis Linn. Diuretic, urinary antiseptic, carminative, digestive, anti-inflammatory, 
Suad kofi Cyperus rotundus Linn. Anti-inflammatory, antirheumatic, hepatoprotective, diuretic, antipyretic, analgesic, used 
for intestinal problems, indigestion, sprue, diarrhoea, dysentery, vomiting and fever 
Waj  Acorus calamus Linn. Sedative (with neuroleptic and antianxiety properties), analgesic, spasmolytic, 
anticonvulsant; used for bronchial catarrh, chronic diarrhoea and dysentery. 
Kundru  Boswellia serrata Roxb. Antiseptic, anti-inflammatory, analgesic. Also used in diarrhoea, dysentery, urinary
disorders. 
Hilteet  Ferula foetida Regel. Stimulates the intestinal and respiratory tracts, used for congested mucus, bronchitis and
whooping cough 
Qaranfal  Syzygium aromaticum 
Linn. 
Antiemetic, stimulant, carminative. Used in dyspepsia, gastric irritation. Used in
inflammatory changes of oral and pharyngeal mucosa. 
Zafran  Crocus sativus Linn. Antispasmodic expectorant (used in dry cough, whooping cough, bronchitis) 
Sibr   Aloe barbadensis Mill. Anti-inflammatory, antimicrobial, used in constipation, releases immune system 
potentiators; enhances function of T cells and interferon production 
Mur  Balsamodendron myrrha 
Nees. 
Anti-inflammatory (on pharyngitis, tonsillitis, common cold and gingivitis), antiseptic,
bacteriostatic, antiviral, expectorant, stomachic, carminative (in dyspepsia), a 
leucocytogenic agent (increases number of white cells in the blood). Blood purifier 
Sirka  Vinegar Vinegar has a variety of functional properties, including antibacterial, anti-infective, 
antioxidant, anticancer activities, hypoglycaemic effect, lipid metabolism regulation etc.
Sandal  Santalum album Linn. Expectorant, antiseptic and bacteriostatic against Gram positive bacteria, diaphoretic,
diuretic. Used as a urinary antiseptic in chronic cystitis 
Kafoor  Cinnamomum camphora 
Linn. 
Reflex expectorant and reflex stimulant of heart and circulation as well as respiration. 
 




relatively potent anti-asthmatic effect. Nigellone 
possesses an antispasmodic efficacy and increases 
mucociliary clearance. Nigella sativa inhibits the 
inflammatory pulmonary responses, decreasing peri 
bronchial inflammatory cell infiltration, alveolar 
septal infiltration, alveolar oedema, alveolar exudate, 
alveolar macrophages, interstitial fibrosis, granuloma 
and necrosis formation significantly in different 
pulmonary aspiration models23. THQ also has 
minimal effect on normal blood coagulation function 
and can effectively reverse sepsis-mediated and 
cancer-mediated thrombosis24. 
Being holistic in nature and Mizaj based 
personalized medicine; Unani physicians do 
individualized treatment of every patient according to 
Mizaj of person, Mizaj of disease, Mizaj of climate 
and extent of pathology. Hence, one disease may be 
treated with several kind of drugs and different 
therapies. 
The principle of Unani treatment according to 
pathology may be planned as10 
 Nuzje Balgham i.e., preparation of morbid humour 
to evacuate (considering the nature of Balgham, 
associated symptoms) 
 Tanqiya Balgham i.e., expulsion of morbid matter 
using expectorants, purgatives, Fasd (removal of 
abnormal humour dam from appropriate veins) and 
emetics. 
 Tadeele Mizaj i.e., normalization of body functions 
which was disturbed due to morbid matters. 
 Taqwiyate Aazae Raeesa w Riya i.e., potentiation 
of important body organs and lungs to avoid 
reoccurrence of such disease (reinfection). 




It may be concluded that there is sufficient 
literature available based on which we may delineate 
the Unani pathology, principles of treatment and use 
of rich treasure of the existing herbal drugs for this 
disease. Since beginning of this disease, there is 
continuous progression in understanding pathology 
based on evidences and findings. There is obvious 
chance of further changes in its pathological 
consideration in future. We are here attempted to 
explain best possible correlation in a broader way. 
These traditional Unani medical knowledge may be 
applied for planning the control, prevention and 
management of COVID-19 safely hoping better 
outcome if practiced rationally as adjuvant with 
conventional treatment. Randomised controlled 
studies may be carried out to evaluate the extent of 
efficacy of Unani medicine in a holistic way on its 
own scientific principles. 
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